FINWIRES · TerminalLIVE
FINWIRES

Biogen Shares Rise After UBS Upgrade

-- Biogen (BIIB) shares rose 2.3% in Wednesday afternoon trading after UBS upgraded the biotechnology company's stock to buy from neutral and boosted its price target to $225 per share from $185.

Trading volume exceeded 700,000 shares, compared with a daily average of over 1.2 million.

Price: $190.25, Change: $+4.30, Percent Change: +2.31%

相关文章